Related Experiment Videos
Helicobacter pylori and reflux disease
1Department of Gastrointestinal Medicine, Royal Adelaide Hospital, Australia. jdent@medicine.adelaide.edu.au
European Journal of Gastroenterology & Hepatology
|September 30, 1999
Summary
The severity of Helicobacter pylori-induced gastritis influences gastro-oesophageal reflux disease. Severe gastritis may protect against reflux by increasing gastric pH, while eradication could increase reflux risk.
Area of Science:
- Gastroenterology and Infectious Diseases
Background:
- The relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease (GERD) is a significant clinical concern.
- Evidence suggests that the severity of H. pylori-induced gastritis plays a crucial role in determining the clinical impact on GERD.
- Severe gastritis may elevate gastric pH, potentially offering a protective effect against reflux disease.
Purpose of the Study:
- To analyze the complex interaction between H. pylori infection and GERD.
- To differentiate the effects of H. pylori on GERD in patients with duodenal ulcers versus those with gastric ulcers or atrophic gastritis.
- To review the available evidence regarding H. pylori eradication's impact on GERD.
Main Methods:
- Literature analysis and synthesis of existing evidence.
- Examination of the relationship between gastric pH, gastritis severity, and GERD.
- Assessment of confounding factors in studies on H. pylori eradication and peptic ulcer disease.
Main Results:
- Severe H. pylori gastritis, leading to elevated gastric pH, appears protective against GERD.
- H. pylori eradication may increase GERD risk by restoring acid secretion.
- The interaction differs between duodenal ulcer patients and those with gastric ulcer/atrophic gastritis.
Conclusions:
- The impact of H. pylori on GERD is contingent on gastritis severity and its effect on gastric acid secretion.
- H. pylori eradication might exacerbate GERD in susceptible individuals.
- Further research is needed, particularly on the effects of eradication in patients primarily suffering from reflux disease.